The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.514
Bid: 1.518
Ask: 1.528
Change: 0.002 (0.13%)
Spread: 0.01 (0.659%)
Open: 1.52
High: 1.53
Low: 1.51
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB 1H2022 Condensed Separate Financial Results

25 Jul 2022 07:00

RNS Number : 5292T
Commercial Intnl Bank (Egypt) SAE
25 July 2022
 

 Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/5292T_1-2022-7-24.pdf

Commercial International Bank (Egypt) S.A.E.

Condensed Separate Financial Statements

June 30, 2022

Condensed Separate Interim Balance Sheet as at June 30, 2022

 

Notes

Jun. 30, 2022

 

Dec. 31, 2021

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Assets

 

 

 

 

Cash and balances at the central bank

8

41,845,093

 

43,385,222

 

Due from banks

9

56,970,904

 

79,991,287

 

Loans and advances to banks, net

11

1,308,243

 

312,216

 

Loans and advances to customers, net

12

169,610,784

 

144,765,808

 

Derivative financial instruments

 

877,137

 

225,376

 

Investments

 

 

 

- Financial Assets at Fair Value through P&L

13

1,648

 

240,987

 

- Financial Assets at Fair Value through OCI

13

215,842,642

 

192,390,931

 

- Financial Assets at Amortized cost

13

19,723,117

 

20,318,767

 

- Investments in associates and subsidiaries

14

1,064,250

 

1,014,350

 

Other assets

15

11,626,924

 

11,141,917

 

Deferred tax assets (Liabilities)

 

354,638

 

460,026

 

Property and equipment

16

2,391,033

 

2,404,237

 

Total assets

 

521,616,413

 

496,651,124

 

Liabilities and equity

 

 

 

Liabilities

 

 

 

Due to banks

17

2,969,822

 

862,759

 

Due to customers

18

427,556,083

 

406,100,916

 

Derivative financial instruments

 

34,934

 

265,265

 

Current income tax liabilities

2,330,166

 

2,234,985

 

Other liabilities

19

9,972,432

 

8,021,310

 

Issued debt instruments

20

1,864,924

 

1,557,263

 

Other loans

 

5,987,651

 

5,140,782

 

Other Provisions

21

5,355,635

 

3,539,676

 

Total liabilities

 

456,071,647

 

427,722,956

 

Equity

 

 

 

 

Issued and paid up capital

 

19,825,134

 

19,702,418

 

Reserves

36,022,139

 

33,767,423

 

Reserve for employee stock ownership plan (ESOP)

 

1,555,725

 

1,674,392

 

Retained earnings *

 

8,141,768

 

13,783,935

 

Total equity and net profit for the period / year

 

65,544,766

 

68,928,168

 

Total liabilities and equity

 

521,616,413

 

496,651,124

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

(Review report attached)

 

 

* Including net profit for the current period

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Managing Director

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Income Statement for the period ended June 30, 2022

 

 

 

 

Notes

 

 

Jun. 30, 2022

 

Jun. 30, 2021

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Interest and similar income

24,258,160

 

20,975,491

 

Interest and similar expense

(10,562,668)

 

(9,302,462)

 

Net interest income

13,695,492

 

11,673,029

 

 

 

 

 

Fee and commission income

2,408,556

 

1,798,447

 

Fee and commission expense

(1,072,802)

 

(687,129)

 

Net fee and commission income

1,335,754

 

1,111,318

 

 

 

 

 

Dividend income

 

62,799

 

63,572

 

Net trading income

5

 

1,013,504

 

274,657

 

Profits (Losses) on financial investments

13

 

1,065,443

 

577,519

 

Administrative expenses

 

(3,233,444)

 

(2,918,943)

 

Other operating (expenses) income

6

(2,509,857)

 

(1,113,292)

 

Impairment release (charges) for credit losses

 

 

(14,449)

 

(1,019,076)

 

Profit before income tax

 

11,415,242

 

8,648,784

 

 

 

 

 

Income tax expense

25

(3,110,536)

 

(2,590,270)

 

Deferred tax assets (Liabilities)

25

(530,715)

 

18,828

 

Net profit for the period

 

7,773,991

 

6,077,342

 

 

 

 

 

Earning per share

7

 

 

 

Basic

3.48

 

2.75

 

Diluted

3.44

 

2.71

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

CEO & Managing Director

 

Sherif Samy

 

Chairman

 

 

 

 

 

Condensed Separate Interim statement of Comprehensive Income for the period ended June 30, 2022

 

 

 

 

Jun. 30, 2022

 

Jun. 30, 2021

 

EGP Thousands

 

EGP Thousands

 

 

 

 

Net profit for the period

 

7,773,991

 

6,077,342

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income after income tax

(7,358,230)

 

(1,624,416)

 

Transferred from reserve on disposal of financial assets at fair value through OCI

(4,227)

 

(104,406)

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

104,188

 

(54,113)

 

Total comprehensive income for the period

515,722

 

4,294,407

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended June 30, 2022

 

 

Notes

Jun. 30, 2022

 

Jun. 30, 2021

EGP Thousands

 

EGP Thousands

 

 

Cash flow from operating activities

 

 

Profit before income tax

11,415,242

 

8,648,784

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

Fixed assets depreciation

 

16

427,873

 

411,612

Impairment charge for credit losses (Loans and advances to customers and banks)

 

 

(94,868)

 

1,060,008

Other provisions charges

 

21

1,513,984

 

350,323

Impairment charge for credit losses (due from banks)

 

 

5,357

 

13,181

Impairment (Released) charge for credit losses (financial investments)

103,960

 

(54,113)

Impairment (Released) charge for other assets

(277,768)

 

25,524

Exchange revaluation differences for financial assets at fair value through OCI and AC

(2,840,747)

 

50,039

Impairment (Released) charge financial assets at fair value through OCI

-

 

(72,957)

Utilization of other provisions

 

21

(1,707)

 

(44,173)

Other provisions no longer used

 

21

(267)

 

(9,145)

Exchange differences of other provisions

 

21

303,949

 

(9,196)

Losses (profits) from selling property and equipment

 

 

(1,142)

 

(1,250)

Losses (profits) from selling financial investments

 

13

(1,065,443)

 

(514,837)

Shares based payments

 

 

384,255

 

316,514

Impairment (Released) charges of investments in associates and subsidiaries

-

 

10,275

Operating losses (profits) before changes in operating assets and liabilities

9,872,678

 

10,180,589

 

 

 

Net decrease (increase) in assets and liabilities

 

 

Due from banks

13,240,715

 

(8,642,436)

Financial assets at fair value through P&L

 

13

239,339

 

151,530

Derivative financial instruments

 

 

(882,092)

 

(19,897)

Loans and advances to banks and customers

 

11 - 12

(25,746,135)

 

(12,680,083)

Other assets

 

 

(291,414)

 

(1,944,779)

Due to banks

 

17

2,107,063

 

(7,502,230)

Due to customers

 

18

21,455,167

 

44,869,003

Current income tax obligations paid

 

 

(780,370)

 

(973,779)

Other liabilities

 

 

(283,863)

 

794,030

Net cash used in (generated from) operating activities

 

 

18,931,088

 

24,231,948

 

 

 

Cash flow from investing activities

 

 

Proceeds (payments) for investment in associates.

(49,900)

 

(158,360)

Payment for purchases of property, equipment and branches constructions

(312,818)

 

(522,975)

Proceeds from selling property and equipment

1,142

 

1,250

Proceeds from redemption of financial assets at amortized cost

659,761

 

2,654,583

Payment for purchases of financial assets at amortized cost

(41,770)

 

(3,844)

Payment for purchases of financial assets at fair value through OCI

(67,627,930)

 

(111,506,191)

Proceeds from selling financial assets at fair value through OCI

45,512,886

 

71,451,202

Net cash generated from (used in) investing activities

(21,858,629)

 

(38,084,335)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended June 30, 2022 (Cont.)

 

Jun. 30, 2022

 

Jun. 30, 2021

 

EGP Thousands

 

EGP Thousands

 

 

 

 

Cash flow from financing activities

 

 

 

Increase (decrease) in long term loans

846,869

 

(2,120,154)

 

Dividend paid

(4,410,322)

 

(1,360,652)

 

Increase (decrease) in issued debt instruments

307,661

 

-

 

Capital increase

122,716

 

-

 

Net cash generated from (used in) financing activities

(3,133,076)

 

(3,480,806)

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the period

(6,060,617)

 

(17,333,193)

 

Beginning balance of cash and cash equivalent

60,891,899

 

75,965,247

 

Cash and cash equivalent at the end of the period

54,831,282

 

58,632,054

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

Cash and balances at the central bank

41,845,093

 

31,792,597

 

Due from banks

57,016,700

 

79,116,502

 

Treasury bills and other governmental notes

10

76,375,291

 

58,677,132

 

Obligatory reserve balance with CBE

 

(36,065,936)

 

(26,239,755)

 

Due from banks with maturities more than three months

(12,494,125)

 

(26,293,821)

 

Treasury bills with maturity more than three months

(71,845,741)

 

(58,420,601)

 

Total cash and cash equivalent

54,831,282

 

58,632,054

 

'

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended June 30, 2021

 

Jun. 30, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

Capital increase

-

-

-

-

-

-

-

-

-

-

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

Net profit of the year

-

-

-

-

-

-

-

6,077,342

-

6,077,342

Transferred from reserve of financial assets at fair value through OCI

-

-

-

-

-

(104,406)

-

104,406

-

-

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(1,624,416)

-

-

-

(1,624,416)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

(54,113)

-

-

-

(54,113)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

316,514

316,514

Ending balance

14,776,813

3,293,074

33,186,137

1,549,445

16,000

2,188,052

9,141

6,367,810

1,381,162

62,767,634

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended June 30, 2022

 

 

 

Jun. 30, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

EGP Thousands

 

Beginning balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

639,231

9,141

13,783,935

1,674,392

68,928,168

 

 

 

 

Capital increase

122,716

-

-

-

-

-

-

-

-

122,716

 

 

 

 

Transferred to reserves

-

670,872

8,836,326

-

2,947

-

-

(9,007,223)

(502,922)

-

 

 

 

 

Dividend paid

-

-

-

-

-

-

-

(4,410,322)

-

(4,410,322)

 

 

 

 

Net profit of the year

-

-

-

-

-

-

-

7,773,991

-

7,773,991

 

 

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(4,227)

-

4,227

-

-

 

 

 

 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

-

-

-

 

 

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(7,358,230)

-

-

-

(7,358,230)

 

 

 

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,840

(2,840)

-

-

 

 

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

104,188

-

-

-

104,188

 

 

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

384,255

384,255

 

 

 

 

Ending balance

19,825,134

3,963,946

37,096,858

1,549,445

18,947

(6,619,038)

11,981

8,141,768

1,555,725

65,544,766

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DGGDRLUDDGDS
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.